Skip to main content
SpringerLink
Log in

Infections After Cardiac Transplantation

  • Chapter
  • First Online:
Heart Failure

  • 4764 Accesses

Abstract

Increasing understanding of the epidemiology of post-transplant infections has led the development of preventative strategies that have reduced, though not eliminated, the risk of many serious infections after transplantation. At the same time, the rise of antimicrobial resistance has posed new challenges for the transplant recipient and clinician. This chapter discusses pre-transplant screening and treatment of pre-transplant infections; early post-transplant infectious complications including donor-transmitted infections; and a wide variety of bacterial, viral, and fungal pathogens that can affect the heart transplant recipient. Immunizations and strategies for safer living are highlighted. Effects of pathogens on allograft function and areas of active research are noted. The interested reader is encouraged to consult existing guidelines (see below) for further detailed recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Razonable RR, Humar A. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013;13:93–106.

    Article  CAS  PubMed  Google Scholar 

  2. Hannan MM, Husain S, Mattner F, Danziger-Isakov L, Drew RJ, Corey GR, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant. 2011;30(4):375–84.

    Article  PubMed  Google Scholar 

  3. Husain S, Mooney ML, Danziger-Isakov L, Mattner F, Singh N, Avery R, et al. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant. 2011;30(4):361–74.

    Article  PubMed  Google Scholar 

  4. Mooney ML Hannan MM, Husain S, Kirklin JK. ISHLT monograph series volume 5: diagnosis and management of infectious diseases in cardiothoracic transplantation and mechanical circulatory support. Int Soc Heart Lung Transplant. 2011;5.

    Google Scholar 

  5. Snydman DR, Limaye AP, Potena L, Zamora MR. Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc. 2011;43(3 Suppl):S1–S17.

    Article  PubMed  Google Scholar 

  6. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, Humar A, Transplantation Society International CMV Consensus Group. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96:333–60.

    Article  CAS  PubMed  Google Scholar 

  7. Garzoni C. Multiply resistant gram-positive bacteria methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus (MRSA, VISA, VRSA) in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S41–9.

    Article  PubMed  Google Scholar 

  8. van Duin D, van Delden C. Multidrug resistant gram-negative bacteria infections in solid organ transplantation. Am J Transplant. 2013;13:31–41.

    Article  PubMed  CAS  Google Scholar 

  9. Patel G, Snydman DR. Vancomycin-resistant enterococcus infection in solid organ transplantation. Am J Transplant. 2013;13:59–67.

    Article  CAS  PubMed  Google Scholar 

  10. Dubberke ER, Burdette SD. Clostridium difficile infections in solid organ transplantation. Am J Transplant. 2013;13:42–9.

    Article  CAS  PubMed  Google Scholar 

  11. Potena L, Holweg CT, Vana ML, Bashyam L, Rajamani J, McCormick AL, et al. Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. J Clin Microbiol. 2007;45(6):1804–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Potena L, Valantine HA. Cytomegalovirus-associated allograft rejection in heart transplant patients. Curr Opin Infect Dis. 2007;20(4):425–31.

    Article  PubMed  Google Scholar 

  13. Fischer SA, Lu K. Screening of donor and recipient in solid organ transplantation. Am J Transplant. 2013;13:9–21.

    Article  CAS  PubMed  Google Scholar 

  14. Gordon SM, Schmitt SK, Jacobs M, Smedira NM, Goormastic M, Banbury MK, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg. 2001;72(3):725–30.

    Article  CAS  PubMed  Google Scholar 

  15. McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE. Implantable LVAD infections: implications for permanent use of the device. Ann Thorac Surg. 1996;61(1):359–65 ; discussion 372–3.

    Article  CAS  PubMed  Google Scholar 

  16. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72.

    Article  CAS  PubMed  Google Scholar 

  17. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416.

    Article  Google Scholar 

  18. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458–77.

    Article  PubMed  Google Scholar 

  19. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Baddour LM, Wilson WR, Bayer AS, Fowler Jr VG, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23):e394.

    Article  PubMed  Google Scholar 

  21. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103–20.

    Article  PubMed  Google Scholar 

  22. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625–63.

    Article  PubMed  Google Scholar 

  23. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41(10):1373–406.

    Article  PubMed  Google Scholar 

  24. Bagdasarian NG, Malani AN, Pagani FD, Malani PN. Fungemia associated with left ventricular assist device support. J Card Surg. 2009;24(6):763–5.

    Article  PubMed  Google Scholar 

  25. Beiras-Fernandez A, Kur F, Kiefer S, Sodian R, Schmoeckel M, Weis M, et al. Multidrug-resistant gram-positive infections in patients with ventricular assist devices: the role of daptomycin. Transplant Proc. 2009;41(6):2589–91.

    Article  CAS  PubMed  Google Scholar 

  26. Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010;363(21):2004–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Calabrese LH, Albrecht M, Young J, McCarthy P, Haug M, Jarcho J, et al. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med. 2003;348(23):2323–8.

    Article  PubMed  Google Scholar 

  28. Bertani A, Grossi P, Vitulo P, D'Ancona G, Arcadipane A, Nanni Costa A, et al. Successful lung transplantation in an HIV- and HBV-positive patient with cystic fibrosis. Am J Transplant. 2009;9(9):2190–6.

    Article  CAS  PubMed  Google Scholar 

  29. Blumberg EA, Rogers CC. HIV in solid organ transplantation. Am J Transplant. 2013;13:169–78.

    Article  CAS  PubMed  Google Scholar 

  30. Kim SY, Jung GS, Kim SK, Chang J, Kim MS, Kim YS, et al. Comparison of the tuberculin skin test and interferon-gamma release assay for the diagnosis of latent tuberculosis infection before kidney transplantation. Infection. 2013;41(1):103–10.

    Article  CAS  PubMed  Google Scholar 

  31. Keating MR, Daly JS. Nontuberculous mycobacterial infections in solid organ transplantation. Am J Transplant. 2013;13:77–82.

    Article  CAS  PubMed  Google Scholar 

  32. Danziger-Isakov L, Kumar D. Vaccination in solid organ transplantation. Am J Transplant. 2013;311:317.

    Google Scholar 

  33. Kumar D, Blumberg EA, Danziger-Isakov L, Kotton CN, Halasa NB, Ison MG, et al. Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant. 2011;11(10):2020–30.

    Article  CAS  PubMed  Google Scholar 

  34. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741–51.

    Article  CAS  PubMed  Google Scholar 

  35. Ramos A, Asensio A, Munez E, Torre-Cisneros J, Blanes M, Carratala J, et al. Incisional surgical infection in heart transplantation. Transpl Infect Dis. 2008;10(4):298–302.

    Article  CAS  PubMed  Google Scholar 

  36. Ison MG, Grossi P. Donor-derived infections in solid organ transplantation. Am J Transplant. 2013;13:22–30.

    Article  PubMed  Google Scholar 

  37. Organ Procurement and Transplantation Network (OPTN) Policies. http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_2.pdf

  38. https://www.whitehouse.gov/the-press-office/2013/11/21/statement-president-hiv-organ-policy-equity-hope-act

  39. Ison MG, Llata E, Conover CS, Friedewald JJ, Gerber SI, Grigoryan A, et al. Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant. 2011;11(6):1218–25.

    Article  CAS  PubMed  Google Scholar 

  40. Humar A, Morris M, Blumberg E, Freeman R, Preiksaitis J, Kiberd B, et al. Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant. 2010;10(4):889–99.

    Article  CAS  PubMed  Google Scholar 

  41. Seem DL, Lee I, Umscheid CA, Kuehnert MJ. PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep. 2013;128:247–343.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Burket JS, Chenoweth CE, Meyer TL, Barg NL. Donor-to-recipient transmission of bacteria as an unusual cause of mediastinitis in a heart transplant recipient. Infect Control Hosp Epidemiol. 1999;20(2):132–3.

    Article  CAS  PubMed  Google Scholar 

  43. Little DM, Farrell JG, Cunningham PM, Hickey DP. Donor sepsis is not a contraindication to cadaveric organ donation. QJM. 1997;90(10):641–2.

    Article  CAS  PubMed  Google Scholar 

  44. Lopez-Navidad A, Domingo P, Caballero F, Gonzalez C, Santiago C. Successful transplantation of organs retrieved from donors with bacterial meningitis. Transplantation. 1997;64(2):365–8.

    Article  CAS  PubMed  Google Scholar 

  45. Kubak BM, Gregson AL, Pegues DA, Leibowitz MR, Carlson M, Marelli D, et al. Use of hearts transplanted from donors with severe sepsis and infectious deaths. J Heart Lung Transplant. 2009;28(3):260–5.

    Article  PubMed  Google Scholar 

  46. Ison MG, Hager J, Blumberg E, Burdick J, Carney K, Cutler J, et al. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant. 2009;9(8):1929–35.

    Article  CAS  PubMed  Google Scholar 

  47. Caliendo AM. Editorial commentary: the long road toward standardization of viral load testing for cytomegalovirus. Clin Infect Dis. 2013;56(3):374–5.

    Article  PubMed  Google Scholar 

  48. Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med. 1992;326(18):1182–6.

    Article  CAS  PubMed  Google Scholar 

  49. Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2004;4(4):611–20.

    Article  CAS  PubMed  Google Scholar 

  50. Humar A, Limaye AP, Blumberg EA, Hauser IA, Vincenti F, Jardine AG, et al. Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. Transplantation. 2010;90(12):1427–31.

    Article  CAS  PubMed  Google Scholar 

  51. Palmer SM, Limaye AP, Banks M, Gallup D, Chapman J, Lawrence EC, et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med. 2010;152(12):761–9.

    Article  PubMed  Google Scholar 

  52. Valantine HA, Luikart H, Doyle R, Theodore J, Hunt S, Oyer P, et al. Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone. Transplantation. 2001;72(10):1647–52.

    Article  CAS  PubMed  Google Scholar 

  53. Snydman DR, Kistler KD, Ulsh P, Bergman GE, Vensak J, Morris J. The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database. Clin Transplant. 2011;25(4):E455–62.

    Article  PubMed  Google Scholar 

  54. Snydman DR, Kistler KD, Ulsh P, Morris J. Cytomegalovirus prevention and long-term recipient and graft survival in pediatric heart transplant recipients. Transplantation. 2010;90(12):1432–8.

    Article  PubMed  Google Scholar 

  55. Singh N. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients. Clin Infect Dis. 2001;32(5):742–51.

    Article  CAS  PubMed  Google Scholar 

  56. Singh N. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence. Clin Infect Dis. 2005;40(5):704–8.

    Article  PubMed  Google Scholar 

  57. Snydman DR. Cytomegalovirus prevention strategies: the case for prophylaxis. Am J Transplant. 2009;9(5):1254.

    Article  CAS  PubMed  Google Scholar 

  58. Keay S, Oldach D, Wiland A, Klassen D, Schweitzer E, Abruzzo LV, et al. Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipients. Clin Infect Dis. 1998;26(3):596–600.

    Article  CAS  PubMed  Google Scholar 

  59. Fateh-Moghadam S, Bocksch W, Wessely R, Jager G, Hetzer R, Gawaz M. Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy. Transplantation. 2003;76(10):1470–4.

    Article  PubMed  Google Scholar 

  60. Koskinen PK, Kallio EA, Tikkanen JM, Sihvola RK, Hayry PJ, Lemstrom KB. Cytomegalovirus infection and cardiac allograft vasculopathy. Transpl Infect Dis. 1999;1(2):115–26.

    Article  CAS  PubMed  Google Scholar 

  61. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989;261(24):3561–6.

    Article  CAS  PubMed  Google Scholar 

  62. Luckraz H, Charman SC, Wreghitt T, Wallwork J, Parameshwar J, Large SR. Does cytomegalovirus status influence acute and chronic rejection in heart transplantation during the ganciclovir prophylaxis era? J Heart Lung Transplant. 2003;22(9):1023–7.

    Article  PubMed  Google Scholar 

  63. Mahle WT, Fourshee MT, Naftel DM, Alejos JC, Caldwell RL, Uzark K, et al. Does cytomegalovirus serology impact outcome after pediatric heart transplantation? J Heart Lung Transplant. 2009;28(12):1299–305.

    Article  PubMed  Google Scholar 

  64. Valantine HA, Gao SZ, Menon SG, Renlund DG, Hunt SA, Oyer P, et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation. 1999;100(1):61–6.

    Article  CAS  PubMed  Google Scholar 

  65. Everett JP, Hershberger RE, Norman DJ, Chou S, Ratkovec RM, Cobanoglu A, et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant. 1992;11(3 Pt 2):S133–7.

    CAS  PubMed  Google Scholar 

  66. Arkonac B, Mauck KA, Chou S, Hosenpud JD. Low multiplicity cytomegalovirus infection of human aortic smooth muscle cells increases levels of major histocompatibility complex class I antigens and induces a proinflammatory cytokine milieu in the absence of cytopathology. J Heart Lung Transplant. 1997;16(10):1035–45.

    CAS  PubMed  Google Scholar 

  67. Tu W, Potena L, Stepick-Biek P, Liu L, Dionis KY, Luikart H, et al. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation. 2006;114(15):1608–15.

    Article  PubMed  Google Scholar 

  68. Potena L, Grigioni F, Magnani G, Lazzarotto T, Musuraca AC, Ortolani P, et al. Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients. J Heart Lung Transplant. 2009;28(5):461–7.

    Article  PubMed  Google Scholar 

  69. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, Schooley RT, Isaacson D, Doran M, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation. 1992;53(1):68–72.

    Article  CAS  PubMed  Google Scholar 

  70. Hibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlethwaite JR, Neylan JF, et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995;123(1):18–26.

    Article  CAS  PubMed  Google Scholar 

  71. Eisen HJ, Tuzcu EM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 2003;349(9):847–58.

    Article  CAS  PubMed  Google Scholar 

  72. Allen UD, Preiksaitis JK. Epstein-Barr virus and posttransplant lymphoproliferative disease in solid organ transplantation. Am J Transplant. 2013;13:107–20.

    Article  CAS  PubMed  Google Scholar 

  73. McDiarmid SV, Jordan S, Kim GS, Toyoda M, Goss JA, Vargas JH, et al. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation. 1998;66(12):1604–11.

    Article  CAS  PubMed  Google Scholar 

  74. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med. 1990;323(25):1723–8.

    Article  CAS  PubMed  Google Scholar 

  75. Green M, Cacciarelli TV, Mazariegos GV, Sigurdsson L, Qu L, Rowe DT, et al. Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation. 1998;66(12):1641–4.

    Article  CAS  PubMed  Google Scholar 

  76. Funch DP, Walker AM, Schneider G, Ziyadeh NJ, Pescovitz MD. Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant. 2005;5(12):2894–900.

    Article  CAS  PubMed  Google Scholar 

  77. Ljungman P, Singh N. Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. J Clin Virol. 2006;37(Suppl 1):S87–91.

    Article  CAS  PubMed  Google Scholar 

  78. Hosseini-Moghaddam SM, Soleimanirahbar A, Mazzulli T, Rotstein C, Husain S. Post renal transplantation Kaposi’s sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy. Transpl Infect Dis. 2012;14(4):338–45.

    Article  CAS  PubMed  Google Scholar 

  79. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010;10(8):521–6.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Krinzman S, Basgoz N, Kradin R, Shepard JA, Flieder DB, Wright CD, et al. Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants. J Heart Lung Transplant. 1998;17(2):202–10.

    CAS  PubMed  Google Scholar 

  81. Michaels MG, Fonseca-Aten M, Green M, Charsha-May D, Friedman B, Seikaly M, et al. Respiratory syncytial virus prophylaxis: a survey of pediatric solid organ transplant centers. Pediatr Transplant. 2009;13(4):451–6.

    Article  PubMed  Google Scholar 

  82. Kumar D, Erdman D, Keshavjee S, Peret T, Tellier R, Hadjiliadis D, et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant. 2005;5(8):2031–6.

    Article  PubMed  Google Scholar 

  83. Caliendo AM. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin Infect Dis. 2011;52(Suppl 4):S326–30.

    Article  PubMed  Google Scholar 

  84. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep. 2011;60(1):1–28.

    Google Scholar 

  85. Pelaez A, Lyon GM, Force SD, Ramirez AM, Neujahr DC, Foster M, et al. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. J Heart Lung Transplant. 2009;28(1):67–71.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Shah JN, Chemaly RF. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood. 2011;117(10):2755–63.

    Article  CAS  PubMed  Google Scholar 

  87. Shirali GS, Ni J, Chinnock RE, Johnston JK, Rosenthal GL, Bowles NE, et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med. 2001;344(20):1498–503.

    Article  CAS  PubMed  Google Scholar 

  88. Eid AJ, Posfay-Barbe KM. Parvovirus B19 in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S147–50.

    Article  PubMed  Google Scholar 

  89. Kaltsas A, Sepkowitz K. Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host. Curr Opin Infect Dis. 2012;25(4):423–30.

    Article  PubMed  Google Scholar 

  90. Ko WJ, Chou NK, Hsu RB, Chen YS, Wang SS, Chu SH, et al. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area. J Heart Lung Transplant. 2001;20(8):865–75.

    Article  CAS  PubMed  Google Scholar 

  91. Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, et al. Solid organ transplantation from hepatitis B virus – positive donors: consensus guidelines for recipient management. Am J Transplant. 2015;15:1162–72.

    Article  CAS  PubMed  Google Scholar 

  92. Pinney SP, Cheema FH, Hammond K, Chen JM, Edwards NM, Mancini D. Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies. J Heart Lung Transplant. 2005;24(1):34–7.

    Article  PubMed  Google Scholar 

  93. Haji SA, Starling RC, Avery RK, Mawhorter S, Tuzcu EM, Schoenhagen P, et al. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant. 2004;23(3):277–83.

    Article  PubMed  Google Scholar 

  94. Gasink LB, Blumberg EA, Localio AR, Desai SS, Israni AK, Lautenbach E. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients. JAMA. 2006;296(15):1843–50.

    Article  CAS  PubMed  Google Scholar 

  95. Dubberke ER, Sadhu J, Gatti R, Reske KA, DiPersio JF, Devine SM, et al. Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system. Infect Control Hosp Epidemiol. 2007;28(2):208–11.

    Article  PubMed  Google Scholar 

  96. Crook DW, Walker AS, Kean Y, Weiss K, Cornely OA, Miller MA, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clin Infect Dis. 2012;55(Suppl 2):S93–103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA, et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 2007;44(10):1307–14.

    Article  PubMed  Google Scholar 

  98. Chow JW, Yu VL. Legionella: a major opportunistic pathogen in transplant recipients. Semin Respir Infect. 1998;13(2):132–9.

    CAS  PubMed  Google Scholar 

  99. Singh N, Stout JE, Yu VL. Prevention of Legionnaires’ disease in transplant recipients: recommendations for a standardized approach. Transpl Infect Dis. 2004;6(2):58–62.

    Article  CAS  PubMed  Google Scholar 

  100. Muder RR, Stout JE, Yu VL. Nosocomial Legionella micdadei infection in transplant patients: fortune favors the prepared mind. Am J Med. 2000;108(4):346–8.

    Article  CAS  PubMed  Google Scholar 

  101. Wiesmayr S, Tabarelli W, Stelzmueller I, Nachbaur D, Boesmueller C, Wykypiel H, et al. Listeria meningitis in transplant recipients. Wien Klin Wochenschr. 2005;117(5–6):229–33.

    Article  PubMed  Google Scholar 

  102. Goulet V, Hebert M, Hedberg C, Laurent E, Vaillant V, De Valk H, et al. Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis. Clin Infect Dis. 2012;54(5):652–60.

    Article  PubMed  Google Scholar 

  103. Stamm AM, Smith SH, Kirklin JK, McGiffin DC. Listerial myocarditis in cardiac transplantation. Rev Infect Dis. 1990;12(5):820–3.

    Article  CAS  PubMed  Google Scholar 

  104. Chou NK, Liu LT, Ko WJ, Hsu RB, Chen YS, Yu HY, et al. Various clinical presentations of tuberculosis in heart transplant recipients. Transplant Proc. 2004;36(8):2396–8.

    Article  PubMed  Google Scholar 

  105. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis. 1998;27(5):1266–77.

    Article  CAS  PubMed  Google Scholar 

  106. Munoz P, Palomo J, Munoz R, Rodriguez-Creixems M, Pelaez T, Bouza E. Tuberculosis in heart transplant recipients. Clin Infect Dis. 1995;21(2):398–402.

    Article  CAS  PubMed  Google Scholar 

  107. Antony SJ, Ynares C, Dummer JS. Isoniazid hepatotoxicity in renal transplant recipients. Clin Transplant. 1997;11(1):34–7.

    CAS  PubMed  Google Scholar 

  108. Naqvi R, Akhtar S, Noor H, Saeed T, Bhatti S, Sheikh R, et al. Efficacy of isoniazid prophylaxis in renal allograft recipients. Transplant Proc. 2006;38(7):2057–8.

    Article  CAS  PubMed  Google Scholar 

  109. Vikrant S, Agarwal SK, Gupta S, Bhowmik D, Tiwari SC, Dash SC, et al. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy. Transpl Infect Dis. 2005;7(3–4):99–108.

    Article  CAS  PubMed  Google Scholar 

  110. Longworth SA, Vinnard C, Lee I, Sims KD, Barton TD, Blumberg EA. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study. Transpl Infect Dis. 2014;16:76–83.

    Article  CAS  PubMed  Google Scholar 

  111. Silveira FP, Kusne S. Candida infections in solid organ transplantation. Am J Transplant. 2013;13:220–7.

    Article  CAS  PubMed  Google Scholar 

  112. Neofytos D, Fishman JA, Horn D, Anaissie E, Chang CH, Olyaei A, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2010;12(3):220–9.

    Article  CAS  PubMed  Google Scholar 

  113. Grossi P, Farina C, Fiocchi R, Dalla GD. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation. 2000;70(1):112–6.

    CAS  PubMed  Google Scholar 

  114. Schaenman JM, Rosso F, Austin JM, Baron EJ, Gamberg P, Miller J, et al. Trends in invasive disease due to Candida species following heart and lung transplantation. Transpl Infect Dis. 2009;11(2):112–21.

    Article  CAS  PubMed  Google Scholar 

  115. Garlicki M, Czub P, Filczak K, Wojdyga R, Puchniewicz M, Labus K, et al. A case of Candida albicans mediastinitis after heart transplantation successfully treated with caspofungin. Ann Transplant. 2006;11(1):47–8.

    PubMed  Google Scholar 

  116. Puius YA, Scully B. Treatment of Candida albicans pericarditis in a heart transplant patient. Transpl Infect Dis. 2007;9(3):229–32.

    Article  CAS  PubMed  Google Scholar 

  117. Albes J, Haverich A, Freihorst J, von der Hardt H, Manthey-Stiers F. Management of mycotic rupture of the ascending aorta after heart-lung transplantation. Ann Thorac Surg. 1990;50(6):982–3.

    Article  CAS  PubMed  Google Scholar 

  118. Singh N, Limaye AP, Forrest G, Safdar N, Munoz P, Pursell K, et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation. 2006;81(3):320–6.

    Article  CAS  PubMed  Google Scholar 

  119. Singh N, Husain S. Aspergillosis in solid organ transplantation. Am J Transplant. 2013;13:228–41.

    Article  CAS  PubMed  Google Scholar 

  120. Hamadeh R, Ardehali A, Locksley RM, York MK. Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient. Chest. 1988;94(2):432–3.

    Article  CAS  PubMed  Google Scholar 

  121. Singh N, Limaye AP, Forrest G, Safdar N, Munoz P, Pursell K, et al. Late-onset invasive aspergillosis in organ transplant recipients in the current era. Med Mycol. 2006;44(5):445–9.

    Article  CAS  PubMed  Google Scholar 

  122. Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant. 2003;22(3):258–66.

    Article  PubMed  Google Scholar 

  123. Husain S, Alexander BD, Munoz P, Avery RK, Houston S, Pruett T, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003;37(2):221–9.

    Article  PubMed  Google Scholar 

  124. Huprikar S, Shoham S. Emerging fungal infections in solid organ transplantation. Am J Transplant. 2013;13:262–71.

    Article  CAS  PubMed  Google Scholar 

  125. Baddley JW, Forrest GN. Cryptococcosis in solid organ transplantation. Am J Transplant. 2013;13:242–9.

    Article  CAS  PubMed  Google Scholar 

  126. Marr KA. Cryptococcus gattii as an important fungal pathogen of western North America. Expert Rev Anti Infect Ther. 2012;10(6):637–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell KJ, et al. Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection. Transplantation. 2005;80(8):1033–9.

    Article  PubMed  Google Scholar 

  128. Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell K, et al. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis. 2005;40(12):1756–61.

    Article  CAS  PubMed  Google Scholar 

  129. Holt CD, Winston DJ, Kubak B, Imagawa DK, Martin P, Goldstein L, et al. Coccidioidomycosis in liver transplant patients. Clin Infect Dis. 1997;24(2):216–21.

    Article  CAS  PubMed  Google Scholar 

  130. Cuellar-Rodriguez J, Avery RK, Lard M, Budev M, Gordon SM, Shrestha NK, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis. 2009;49(5):710–6.

    Article  CAS  PubMed  Google Scholar 

  131. Keckich DW, Blair JE, Vikram HR, Seville MT, Kusne S. Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipients. Transplantation. 2011;92(1):88–93.

    Article  PubMed  Google Scholar 

  132. Miller R, Assi M. Endemic fungal infections in solid organ transplantation. Am J Transplant. 2013;13:250–61.

    Article  CAS  PubMed  Google Scholar 

  133. Freifeld AG, Wheat LJ, Kaul DR. Histoplasmosis in solid organ transplant recipients: early diagnosis and treatment. Curr Opin Organ Transplant. 2009;14(6):601–5.

    Article  PubMed  Google Scholar 

  134. Serody JS, Mill MR, Detterbeck FC, Harris DT, Cohen MS. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis. 1993;16(1):54–8.

    Article  CAS  PubMed  Google Scholar 

  135. Martin SI, Fishman JA. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant. 2013;13:272–9.

    Article  CAS  PubMed  Google Scholar 

  136. Gordon SM, LaRosa SP, Kalmadi S, Arroliga AC, Avery RK, Truesdell-LaRosa L, et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis. 1999;28(2):240–6.

    Article  CAS  PubMed  Google Scholar 

  137. Wreghitt TG, Hakim M, Gray JJ, Balfour AH, Stovin PG, Stewart S, et al. Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol. 1989;42(2):194–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  138. Wreghitt TG, Gray JJ, Pavel P, Balfour A, Fabbri A, Sharples LD, et al. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transpl Int. 1992;5(4):197–200.

    Article  CAS  PubMed  Google Scholar 

  139. Gourishankar S, Doucette K, Fenton J, Purych D, Kowalewska-Grochowska K, Preiksaitis J. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Transplantation. 2008;85(7):980–5.

    Article  PubMed  Google Scholar 

  140. Baran DA, Alwarshetty MM, Alvi S, Arroyo LH, Lubitz S, Pinney S, et al. Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers. J Heart Lung Transplant. 2006;25(11):1380–2.

    Article  PubMed  Google Scholar 

  141. Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis. 2009;49(9):1411–23.

    Article  PubMed  PubMed Central  Google Scholar 

  142. Schaeffer MW, Buell JF, Gupta M, Conway GD, Akhter SA, Wagoner LE. Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transplant. 2004;23(7):905–11.

    Article  PubMed  Google Scholar 

  143. El Masry HZ, O'Donnell J. Fatal stongyloides hyperinfection in heart transplantation. J Heart Lung Transplant. 2005;24(11):1980–3.

    Article  PubMed  Google Scholar 

  144. Pinazo MJ, Miranda B, Rodriguez-Villar C, Altclas J, Brunet Serra M, Garcia-Otero EC, et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando). 2011;25(3):91–101.

    Article  Google Scholar 

  145. Casadei D. Chagas’ disease and solid organ transplantation. Transplant Proc. 2010;42(9):3354–9.

    Article  PubMed  Google Scholar 

  146. Kun H, Moore A, Mascola L, Steurer F, Lawrence G, Kubak B, et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis. 2009;48(11):1534–40.

    Article  PubMed  Google Scholar 

  147. Altclas JD, Barcan L, Nagel C, Lattes R, Riarte A. Organ transplantation and Chagas disease. JAMA. 2008;299(10):1134 .author reply 1134-5

    Article  CAS  PubMed  Google Scholar 

  148. Fiorelli AI, Santos RH, Oliveira Jr JL, Lourenco-Filho DD, Dias RR, Oliveira AS, et al. Heart transplantation in 107 cases of Chagas’ disease. Transplant Proc. 2011;43(1):220–4.

    Article  CAS  PubMed  Google Scholar 

  149. Chin-Hong PV, Schwartz BS, Bern C, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in Transplant Working Group. Am J Transplant. 2011;11:672–80.

    Article  CAS  PubMed  Google Scholar 

  150. Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, Levin MJ, et al. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients. PLoS Negl Trop Dis. 2009;3(4):e419.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  151. Diez M, Favaloro L, Bertolotti A, Burgos JM, Vigliano C, Lastra MP, et al. Usefulness of PCR strategies for early diagnosis of Chagas’ disease reactivation and treatment follow-up in heart transplantation. Am J Transplant. 2007;7(6):1633–40.

    Article  CAS  PubMed  Google Scholar 

  152. Trofe-Clark J, Lemonovich TL. Interactions between anti-infective agents and immunosuppressants in solid organ transplantation. Am J Transplant. 2013;318-26.

    Google Scholar 

  153. Jain AK, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, et al. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl. 2002;8(9):841–5.

    Article  PubMed  Google Scholar 

  154. Avery RK, Michaels MG. Strategies for safe living following solid organ transplantation. Am J Transplant. 2013;13:304–10.

    Article  PubMed  Google Scholar 

  155. Avery RK. Influenza vaccines in the setting of solid-organ transplantation: are they safe? Curr Opin Infect Dis. 2012;25(4):464–8.

    Article  PubMed  Google Scholar 

  156. Hurst FP, Lee JJ, Jindal RM, Agodoa LY, Abbott KC. Outcomes associated with influenza vaccination in the first year after kidney transplantation. Clin J Am Soc Nephrol. 2011;6(5):1192–7.

    Article  PubMed  PubMed Central  Google Scholar 

  157. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;61(40):816–9.

    Google Scholar 

  158. Kumar D, Welsh B, Siegal D, Chen MH, Humar A. Immunogenicity of pneumococcal vaccine in renal transplant recipients–three year follow-up of a randomized trial. Am J Transplant. 2007;7(3):633–8.

    Article  CAS  PubMed  Google Scholar 

  159. Kumar D, Chen MH, Wong G, Cobos I, Welsh B, Siegal D, et al. A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients. Clin Infect Dis. 2008;47(7):885–92.

    Article  PubMed  Google Scholar 

  160. Weinberg A, Horslen SP, Kaufman SS, Jesser R, Devoll-Zabrocki A, Fleckten BL, et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant. 2006;6(3):565–8.

    Article  CAS  PubMed  Google Scholar 

  161. Khan S, Erlichman J, Rand EB. Live virus immunization after orthotopic liver transplantation. Pediatr Transplant. 2006;10(1):78–82.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Disease (Transplant/Oncology), Johns Hopkins Hospital, 1830 East Monument Street #449, Baltimore, MD, 21205, USA

    Robin K. Avery MD, FIDSA

Authors
  1. Robin K. Avery MD, FIDSA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robin K. Avery MD, FIDSA .

Editor information

Editors and Affiliations

  1. Division of Cardiology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA

    Howard Eisen

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag London

About this chapter

Cite this chapter

Avery, R.K. (2017). Infections After Cardiac Transplantation. In: Eisen, H. (eds) Heart Failure. Springer, London. https://doi.org/10.1007/978-1-4471-4219-5_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4219-5_23

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4218-8

  • Online ISBN: 978-1-4471-4219-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation